Results 111 to 120 of about 918,306 (202)

The Use of Renal Artery Denervation in Atrial Fibrillation Patients: A Review of Literature

High Yield Medical Reviews
Renal denervation (RDN) is a minimally invasive procedure by which ultrasound guided ablation or radiofrequency ablation is used to target sympathetic nerves within the walls of renal arteries causing a decrease in their activity and consequently, a ...
Qutaiba Shudayfat, Jawad Shitawi, Mohammad Al-Jafari, Sana'a Quran, Julie Owaidat, Mariam A. Nofal, Mohammad Abu-Jeyyab, Abdallah Daseh, Saja Zuaiter   +8 more
doaj   +1 more source

Association between renal sympathetic denervation and arterial stiffness: the ASORAS study. [PDF]

J Hypertens, 2023
Zeijen VJM, Feyz L, Kardys I, Geleijnse ML, Van Mieghem NM, Zijlstra F, Lafeber M, Van Der Geest RJ, Hirsch A, Daemen J.   +9 more
europepmc   +1 more source

Unilateral renal atrophy 4 years after renal sympathetic denervation: a case report. [PDF]

J Hypertens, 2023
Zeijen VJM, Hirsch A, Betjes MGH, Daemen J.   +3 more
europepmc   +1 more source

Assessment of arterial stiffness to predict blood pressure response to renal sympathetic denervation. [PDF]

EuroIntervention, 2022
Fengler K, Rommel KP, Kriese W, Kresoja KP, Blazek S, Obradovic D, Feistritzer HJ, Lücke C, Gutberlet M, Desch S, Thiele H, Lurz P.   +11 more
europepmc   +1 more source

Long-term follow-up of patients undergoing renal sympathetic denervation. [PDF]

Clin Res Cardiol, 2022
Zeijen VJM, Feyz L, Nannan Panday R, Veen K, Versmissen J, Kardys I, Van Mieghem NM, Daemen J.   +7 more
europepmc   +1 more source

Early Renal Denervation Attenuates Cardiac Dysfunction in Heart Failure With Preserved Ejection Fraction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background The renal sympathetic nervous system modulates systemic blood pressure, cardiac performance, and renal function. Pathological increases in renal sympathetic nerve activity contribute to the pathogenesis of heart failure with preserved ejection
Jake E. Doiron, Zhen Li, Xiaoman Yu, Kyle B. LaPenna, Heather Quiriarte, Timothy D. Allerton, Kashyap Koul, Andrew Malek, Sanjiv J. Shah, Thomas E. Sharp, Traci T. Goodchild, Daniel R. Kapusta, David J. Lefer   +12 more
doaj   +1 more source

Long-term safety and efficacy of renal sympathetic denervation in atrial fibrillation: 3-year results of the AFFORD study. [PDF]

Clin Res Cardiol, 2023
Zeijen VJM, Theuns DA, Feyz L, Saville KA, Bhagwandien R, Kardys I, Van Mieghem NM, Daemen J.   +7 more
europepmc   +1 more source

Increased Sympathetic Renal Innervation in Hemodialysis Patients Is the Anatomical Substrate of Sympathetic Hyperactivity in End-Stage Renal Disease

, 2015
Renal denervation represents an emerging treatment for resistant hypertension in patients with end-stage renal disease, but data about the anatomic substrate of this treatment are lacking.
BOVE, PIERLUIGI, Melino, G, MAURIELLO, ALESSANDRO, Mauriello, A, ANEMONA, LUCIA, MELINO, GENNARO, DI DANIELE, NICOLA, Rovella, V, Servadei, F, Bove, P, Di Daniele, N, Anselmo, A, Giannini, E, ROVELLA, VALENTINA, Anemona, L   +14 more
core   +1 more source

Safety and efficacy of renal sympathetic denervation: a 9-year long-term follow-up of 24-hour ambulatory blood pressure measurements. [PDF]

Front Cardiovasc Med, 2023
Vogt A, Dutzmann J, Nußbaum M, Hoyer D, Tongers J, Schlitt A, Sedding D, Plehn A.   +7 more
europepmc   +1 more source

Sympathetic renal denervation for resistant hypertension : impact on blood pressure and on surrogate markers of target organ damage [PDF]

, 2018
Summary Hypertension is a leading cause of death in developed countries, and although there have been large investments in drugs aiming its control, there is still a staggering contrast between its high prevalence and the low rates of adequate control.
Almeida, Manuel de Sousa
core